Noncirrhotic Portal Hypertension after Trastuzumab Emtansine in HER2-positive Breast Cancer as Determined by Deep Learning-measured Spleen Volume at CT.
Radiology
; 305(3): 606-613, 2022 12.
Article
in En
| MEDLINE
| ID: mdl-35943338
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Breast Neoplasms
/
Deep Learning
/
Ado-Trastuzumab Emtansine
/
Hypertension, Portal
Type of study:
Etiology_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Female
/
Humans
/
Middle aged
Language:
En
Journal:
Radiology
Year:
2022
Document type:
Article